Vaxart, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a VXRT research report →
About the company
Vaxart, Inc. operates as a biotechnology firm currently in the clinical development phase, concentrating its efforts on identifying and advancing novel oral recombinant protein vaccines. The company leverages its unique proprietary platform for delivering these oral vaccine solutions.
- CEO
- Steven Lo
- IPO
- 1981
- Employees
- 105
- HQ
- South San Francisco, CA, US
Price Chart
- Market Cap
- $154.91M
- P/E
- 4.57
- P/S
- 0.61
- P/B
- 1.64
- EV/EBITDA
- 2.37
- Div Yield
- 0.00%
- Gross Margin
- 100.00%
- Op Margin
- 14.94%
- Net Margin
- 14.51%
- ROE
- 61.43%
- ROIC
- 35.71%
- Revenue
- $237.26M · 726.68%
- Net Income
- $16.33M · 124.39%
- EPS
- $0.07 · 150.00%
- Op Income
- $18.07M
- FCF YoY
- 116.70%
- 52W High
- $0.84
- 52W Low
- $0.26
- 50D MA
- $0.64
- 200D MA
- $0.54
- Beta
- 1.09
- Avg Volume
- 395.49K
Get TickerSpark's AI analysis on VXRT
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| May 22, 26 | Watson W. Mark | buy | 10,000 |
| May 19, 26 | Grasman Jeroen Nicolaas | other | 31,395 |
| Apr 23, 26 | BREITMEYER JAMES B | other | 157,400 |
| Apr 23, 26 | BREITMEYER JAMES B | other | 78,800 |
| Apr 23, 26 | BREITMEYER JAMES B | other | 0 |
| Mar 28, 26 | Tucker Sean | other | 3,924 |
| Mar 28, 26 | Cummings James F. | other | 3,292 |
| Mar 24, 26 | Berg Edward B | other | 36,418 |
| Mar 24, 26 | Cummings James F. | other | 30,551 |
| Mar 24, 26 | Lo Steven | other | 126,028 |
Our VXRT coverage
Recent articles, reports, and earnings notes.
No research on VXRT yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate VXRT report →Similar companies
Peers in the same neighborhood.